Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc develops treatments for endocrine and related diseases.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Crinetics Pharmaceuticals' stock, expecting it to rise significantly in value.
Financial Health
Crinetics Pharmaceuticals is generating modest revenue and cash flow, with a stable book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CRNX
MASH Stocks: Could Roche's Deal Spark More M&A?
Roche's $3.5 billion acquisition of 89bio for its liver disease drug highlights the growing MASH treatment market. This deal creates a potential tailwind for other biopharmaceutical companies developing therapies for liver and metabolic conditions.
Published: September 21, 2025
Explore BasketObesity Treatment (Pharma Giants vs Biotech Firms)
Novo Nordisk's major restructuring, driven by intense competition from Eli Lilly, highlights the high-stakes battle in the weight-loss drug market. This theme focuses on other pharmaceutical companies that could benefit from this rivalry, either as innovators with next-generation treatments or as potential acquisition targets.
Published: September 10, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline catalysts
Clinical trial readouts and regulatory milestones can materially move the share price, though outcomes are binary and uncertain.
Endocrine focus
Targets rare hormonal disorders where successful drugs can command premium pricing, but niche markets and commercial execution carry risk.
Financing and risk
Ongoing development may require additional capital, creating dilution risk; keep in mind clinical, regulatory and competitive uncertainties.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
